Matthew McQueen
Concepts (429)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 22 | 2022 | 1177 | 2.140 |
Why?
| Polymorphism, Single Nucleotide | 39 | 2020 | 1880 | 1.880 |
Why?
| Genetic Predisposition to Disease | 26 | 2022 | 2086 | 1.530 |
Why?
| Genetic Linkage | 10 | 2011 | 294 | 1.370 |
Why?
| Waist-Height Ratio | 3 | 2016 | 6 | 1.080 |
Why?
| Body Mass Index | 12 | 2015 | 1959 | 0.930 |
Why?
| Risk-Taking | 4 | 2015 | 333 | 0.890 |
Why?
| Genetic Testing | 9 | 2016 | 381 | 0.780 |
Why?
| Sexual Behavior | 3 | 2013 | 440 | 0.730 |
Why?
| Alcohol Drinking | 6 | 2022 | 651 | 0.720 |
Why?
| Bipolar Disorder | 5 | 2011 | 205 | 0.720 |
Why?
| Siblings | 7 | 2014 | 221 | 0.670 |
Why?
| Genome, Human | 9 | 2014 | 347 | 0.620 |
Why?
| Quantitative Trait, Heritable | 5 | 2016 | 116 | 0.610 |
Why?
| Substance-Related Disorders | 8 | 2020 | 947 | 0.610 |
Why?
| Epidemiology | 1 | 2018 | 14 | 0.610 |
Why?
| Genotype | 18 | 2019 | 1760 | 0.610 |
Why?
| Metabolic Syndrome | 2 | 2016 | 321 | 0.590 |
Why?
| Quantitative Trait Loci | 4 | 2015 | 305 | 0.580 |
Why?
| Alzheimer Disease | 8 | 2011 | 442 | 0.560 |
Why?
| Brain Concussion | 2 | 2021 | 476 | 0.560 |
Why?
| Cardiovascular Diseases | 9 | 2021 | 1727 | 0.540 |
Why?
| Databases, Genetic | 5 | 2012 | 206 | 0.530 |
Why?
| Teaching | 1 | 2018 | 213 | 0.520 |
Why?
| Education, Medical, Undergraduate | 1 | 2018 | 159 | 0.520 |
Why?
| Antisocial Personality Disorder | 2 | 2015 | 156 | 0.510 |
Why?
| Alcoholism | 8 | 2020 | 713 | 0.510 |
Why?
| Longitudinal Studies | 14 | 2020 | 2387 | 0.510 |
Why?
| Athletic Injuries | 2 | 2021 | 456 | 0.510 |
Why?
| Receptors, Nicotinic | 7 | 2013 | 274 | 0.500 |
Why?
| Waist Circumference | 1 | 2015 | 122 | 0.500 |
Why?
| Obesity | 8 | 2016 | 2508 | 0.480 |
Why?
| Genetic Variation | 8 | 2022 | 870 | 0.480 |
Why?
| Humans | 103 | 2022 | 114698 | 0.470 |
Why?
| Impulsive Behavior | 1 | 2015 | 113 | 0.450 |
Why?
| Tobacco Use Disorder | 6 | 2020 | 234 | 0.450 |
Why?
| Public Health | 1 | 2018 | 434 | 0.450 |
Why?
| Blood Pressure | 8 | 2018 | 1538 | 0.440 |
Why?
| Aging | 6 | 2020 | 1618 | 0.430 |
Why?
| Gene-Environment Interaction | 2 | 2014 | 183 | 0.430 |
Why?
| Male | 65 | 2020 | 55606 | 0.420 |
Why?
| Predictive Value of Tests | 3 | 2018 | 1796 | 0.410 |
Why?
| Breast Feeding | 1 | 2015 | 368 | 0.400 |
Why?
| Female | 61 | 2020 | 59520 | 0.400 |
Why?
| Conduct Disorder | 5 | 2015 | 193 | 0.390 |
Why?
| Phenotype | 17 | 2020 | 2796 | 0.390 |
Why?
| Genetic Loci | 4 | 2022 | 262 | 0.370 |
Why?
| Carrier State | 2 | 2021 | 54 | 0.360 |
Why?
| Troponin T | 3 | 2020 | 49 | 0.360 |
Why?
| Adult | 34 | 2020 | 30553 | 0.340 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2010 | 44 | 0.330 |
Why?
| Natriuretic Peptide, Brain | 3 | 2021 | 94 | 0.320 |
Why?
| Pedigree | 3 | 2013 | 460 | 0.320 |
Why?
| Troponin I | 2 | 2020 | 68 | 0.320 |
Why?
| Young Adult | 17 | 2021 | 10471 | 0.320 |
Why?
| Adolescent | 24 | 2021 | 17853 | 0.310 |
Why?
| Apolipoprotein E4 | 2 | 2007 | 32 | 0.310 |
Why?
| Apolipoprotein E2 | 1 | 2007 | 3 | 0.300 |
Why?
| alpha-Macroglobulins | 1 | 2007 | 24 | 0.290 |
Why?
| Biometry | 2 | 2007 | 62 | 0.290 |
Why?
| Body Weight | 5 | 2015 | 869 | 0.280 |
Why?
| Multifactorial Inheritance | 2 | 2022 | 122 | 0.280 |
Why?
| Risk Factors | 21 | 2022 | 8632 | 0.280 |
Why?
| Family | 7 | 2011 | 589 | 0.270 |
Why?
| Myocardial Infarction | 5 | 2020 | 927 | 0.270 |
Why?
| Sodium, Dietary | 3 | 2018 | 36 | 0.270 |
Why?
| Sodium | 2 | 2018 | 183 | 0.270 |
Why?
| Middle Aged | 29 | 2020 | 26738 | 0.260 |
Why?
| Acute Coronary Syndrome | 2 | 2020 | 253 | 0.260 |
Why?
| Memory | 1 | 2007 | 211 | 0.260 |
Why?
| Linkage Disequilibrium | 7 | 2020 | 245 | 0.260 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2005 | 33 | 0.250 |
Why?
| Sodium Nitrite | 2 | 2015 | 37 | 0.250 |
Why?
| Models, Genetic | 8 | 2016 | 562 | 0.250 |
Why?
| Feeding and Eating Disorders | 2 | 2020 | 103 | 0.240 |
Why?
| HIV Infections | 3 | 2013 | 2469 | 0.240 |
Why?
| Asymptomatic Infections | 2 | 2021 | 21 | 0.240 |
Why?
| Myocardium | 2 | 2020 | 913 | 0.230 |
Why?
| Endothelium, Vascular | 3 | 2016 | 847 | 0.230 |
Why?
| Diet, Sodium-Restricted | 2 | 2016 | 34 | 0.230 |
Why?
| Internationality | 2 | 2022 | 143 | 0.230 |
Why?
| Aged | 24 | 2020 | 19074 | 0.220 |
Why?
| Health Status | 2 | 2018 | 722 | 0.220 |
Why?
| Cooperative Behavior | 1 | 2005 | 381 | 0.220 |
Why?
| Viral Load | 2 | 2021 | 405 | 0.210 |
Why?
| Saliva | 2 | 2021 | 188 | 0.210 |
Why?
| Lipids | 3 | 2018 | 580 | 0.210 |
Why?
| Prospective Studies | 9 | 2021 | 6220 | 0.210 |
Why?
| Gastrointestinal Microbiome | 2 | 2020 | 501 | 0.210 |
Why?
| Cholesterol, HDL | 3 | 2016 | 183 | 0.200 |
Why?
| Nerve Tissue Proteins | 4 | 2011 | 529 | 0.200 |
Why?
| Tobacco Use | 1 | 2022 | 60 | 0.200 |
Why?
| Case-Control Studies | 14 | 2019 | 3003 | 0.200 |
Why?
| Mental Disorders | 3 | 2019 | 893 | 0.200 |
Why?
| Neuropsychological Tests | 2 | 2021 | 927 | 0.190 |
Why?
| Reproducibility of Results | 2 | 2021 | 2765 | 0.190 |
Why?
| Hypertension | 3 | 2016 | 1056 | 0.190 |
Why?
| Clinical Laboratory Techniques | 2 | 2020 | 87 | 0.190 |
Why?
| Receptors, GABA-A | 2 | 2014 | 82 | 0.190 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 2 | 2012 | 72 | 0.180 |
Why?
| Alleles | 5 | 2018 | 789 | 0.180 |
Why?
| Diseases in Twins | 2 | 2012 | 174 | 0.170 |
Why?
| Smoking | 4 | 2019 | 1383 | 0.170 |
Why?
| Brachial Artery | 3 | 2016 | 176 | 0.170 |
Why?
| Gene Frequency | 10 | 2011 | 477 | 0.170 |
Why?
| Surgical Procedures, Operative | 2 | 2014 | 207 | 0.170 |
Why?
| Data Interpretation, Statistical | 3 | 2011 | 321 | 0.160 |
Why?
| Multigene Family | 2 | 2011 | 190 | 0.160 |
Why?
| Genetic Markers | 4 | 2014 | 320 | 0.160 |
Why?
| Feces | 2 | 2020 | 373 | 0.160 |
Why?
| Minisatellite Repeats | 1 | 2019 | 38 | 0.160 |
Why?
| Students | 2 | 2021 | 502 | 0.160 |
Why?
| Vascular Stiffness | 3 | 2018 | 407 | 0.150 |
Why?
| Healthy Aging | 1 | 2018 | 18 | 0.150 |
Why?
| Global Health | 3 | 2016 | 287 | 0.150 |
Why?
| Adolescent Behavior | 2 | 2013 | 489 | 0.150 |
Why?
| Schizophrenia | 3 | 2020 | 414 | 0.150 |
Why?
| Burns | 1 | 2021 | 237 | 0.150 |
Why?
| Behavior | 1 | 2019 | 92 | 0.150 |
Why?
| Exercise | 2 | 2018 | 1644 | 0.150 |
Why?
| Biological Specimen Banks | 1 | 2019 | 94 | 0.150 |
Why?
| Marijuana Abuse | 1 | 2020 | 212 | 0.150 |
Why?
| Reference Values | 3 | 2016 | 743 | 0.150 |
Why?
| Risk | 3 | 2020 | 812 | 0.150 |
Why?
| Athletes | 1 | 2021 | 328 | 0.150 |
Why?
| Peptide Fragments | 3 | 2021 | 666 | 0.150 |
Why?
| Genetic Association Studies | 4 | 2014 | 339 | 0.150 |
Why?
| Sodium Pertechnetate Tc 99m | 2 | 1997 | 5 | 0.150 |
Why?
| NAD | 1 | 2018 | 63 | 0.150 |
Why?
| Niacinamide | 1 | 2018 | 63 | 0.150 |
Why?
| Caloric Restriction | 2 | 2018 | 90 | 0.150 |
Why?
| Body Height | 2 | 2015 | 180 | 0.150 |
Why?
| Likelihood Functions | 2 | 2015 | 126 | 0.150 |
Why?
| Mouth | 1 | 2017 | 70 | 0.140 |
Why?
| Cholesterol, LDL | 2 | 2016 | 307 | 0.140 |
Why?
| Hair | 2 | 2015 | 65 | 0.140 |
Why?
| Regional Blood Flow | 2 | 2016 | 424 | 0.140 |
Why?
| Apolipoprotein B-100 | 1 | 2016 | 8 | 0.140 |
Why?
| Risk Assessment | 6 | 2016 | 2968 | 0.140 |
Why?
| Apolipoprotein A-I | 1 | 2016 | 25 | 0.140 |
Why?
| Psychological Trauma | 1 | 2017 | 54 | 0.140 |
Why?
| Gene Regulatory Networks | 2 | 2018 | 228 | 0.130 |
Why?
| Chromosome Mapping | 5 | 2015 | 487 | 0.130 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2016 | 34 | 0.130 |
Why?
| Trehalose | 1 | 2016 | 30 | 0.130 |
Why?
| United States | 5 | 2016 | 12186 | 0.130 |
Why?
| Cross-Sectional Studies | 5 | 2013 | 4410 | 0.130 |
Why?
| Sexual Partners | 2 | 2013 | 161 | 0.120 |
Why?
| Educational Status | 2 | 2014 | 412 | 0.120 |
Why?
| Proteome | 1 | 2018 | 339 | 0.120 |
Why?
| Amino Acids | 1 | 2018 | 448 | 0.120 |
Why?
| Europe | 4 | 2022 | 334 | 0.120 |
Why?
| ROC Curve | 1 | 2016 | 442 | 0.120 |
Why?
| Adolescent Medicine | 1 | 2014 | 33 | 0.120 |
Why?
| Quality Control | 1 | 2014 | 144 | 0.120 |
Why?
| Carotid Arteries | 1 | 2015 | 180 | 0.120 |
Why?
| Health Surveys | 1 | 2016 | 443 | 0.110 |
Why?
| Telomere | 1 | 2016 | 202 | 0.110 |
Why?
| Colorado | 4 | 2021 | 4100 | 0.110 |
Why?
| Metabolomics | 1 | 2018 | 521 | 0.110 |
Why?
| Malawi | 1 | 2013 | 48 | 0.110 |
Why?
| Hindlimb | 1 | 2014 | 130 | 0.110 |
Why?
| Albuminuria | 1 | 2014 | 164 | 0.110 |
Why?
| Locomotion | 1 | 2014 | 80 | 0.110 |
Why?
| Income | 1 | 2014 | 167 | 0.110 |
Why?
| Nervous System Physiological Phenomena | 1 | 2013 | 21 | 0.110 |
Why?
| Aorta | 1 | 2015 | 386 | 0.110 |
Why?
| Polymorphism, Genetic | 3 | 2012 | 610 | 0.100 |
Why?
| Patient Outcome Assessment | 1 | 2014 | 122 | 0.100 |
Why?
| Transplantation | 1 | 2013 | 23 | 0.100 |
Why?
| Metabolic Networks and Pathways | 1 | 2014 | 168 | 0.100 |
Why?
| Physical Exertion | 1 | 2014 | 209 | 0.100 |
Why?
| DEAD-box RNA Helicases | 1 | 2013 | 56 | 0.100 |
Why?
| Software | 2 | 2014 | 530 | 0.100 |
Why?
| Myocardial Ischemia | 1 | 2014 | 235 | 0.100 |
Why?
| Age Factors | 6 | 2020 | 2894 | 0.100 |
Why?
| Substance Abuse, Intravenous | 1 | 2013 | 99 | 0.100 |
Why?
| Pravastatin | 1 | 1992 | 28 | 0.100 |
Why?
| Lovastatin | 1 | 1992 | 26 | 0.100 |
Why?
| Receptors, Oxytocin | 1 | 2012 | 23 | 0.100 |
Why?
| Genetic Heterogeneity | 3 | 2008 | 48 | 0.100 |
Why?
| Hyperlipoproteinemia Type II | 1 | 1992 | 26 | 0.100 |
Why?
| Aged, 80 and over | 5 | 2020 | 6347 | 0.100 |
Why?
| Haplotypes | 6 | 2010 | 448 | 0.100 |
Why?
| Puberty | 1 | 2013 | 135 | 0.100 |
Why?
| Postural Balance | 1 | 2014 | 183 | 0.100 |
Why?
| Physical Fitness | 1 | 2013 | 179 | 0.100 |
Why?
| Double-Blind Method | 4 | 2018 | 1660 | 0.090 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2011 | 10 | 0.090 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2011 | 43 | 0.090 |
Why?
| Receptors, Immunologic | 2 | 2013 | 201 | 0.090 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2011 | 56 | 0.090 |
Why?
| Interleukins | 1 | 2013 | 236 | 0.090 |
Why?
| Quality of Life | 1 | 2021 | 2353 | 0.090 |
Why?
| Receptors, Dopamine D4 | 1 | 2011 | 24 | 0.090 |
Why?
| Motor Activity | 1 | 2015 | 640 | 0.090 |
Why?
| Behavior, Animal | 1 | 2014 | 458 | 0.090 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2011 | 41 | 0.090 |
Why?
| Glucose Metabolism Disorders | 1 | 2010 | 10 | 0.090 |
Why?
| Odds Ratio | 4 | 2016 | 953 | 0.090 |
Why?
| Tissue Donors | 1 | 2013 | 316 | 0.090 |
Why?
| Child Behavior Disorders | 1 | 2011 | 131 | 0.090 |
Why?
| Catechol O-Methyltransferase | 1 | 2010 | 17 | 0.090 |
Why?
| Microbiota | 1 | 2017 | 647 | 0.090 |
Why?
| Hepatitis C | 1 | 2013 | 219 | 0.090 |
Why?
| Life Expectancy | 1 | 2010 | 51 | 0.090 |
Why?
| Diet, Reducing | 1 | 2010 | 76 | 0.080 |
Why?
| Energy Metabolism | 1 | 2015 | 731 | 0.080 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2017 | 758 | 0.080 |
Why?
| Environment | 2 | 2010 | 332 | 0.080 |
Why?
| Psychology, Adolescent | 1 | 2009 | 63 | 0.080 |
Why?
| Twins, Dizygotic | 1 | 2010 | 182 | 0.080 |
Why?
| Longevity | 1 | 2010 | 137 | 0.080 |
Why?
| Hyperhomocysteinemia | 1 | 2009 | 24 | 0.080 |
Why?
| Prevalence | 5 | 2013 | 2251 | 0.080 |
Why?
| Twins, Monozygotic | 1 | 2010 | 210 | 0.080 |
Why?
| Genes, Neoplasm | 1 | 2008 | 20 | 0.080 |
Why?
| Cognition | 1 | 2015 | 989 | 0.080 |
Why?
| Homocysteine | 1 | 2009 | 136 | 0.080 |
Why?
| Raphe Nuclei | 2 | 1999 | 110 | 0.080 |
Why?
| Myosin Type V | 1 | 2008 | 9 | 0.080 |
Why?
| Universities | 2 | 2021 | 340 | 0.080 |
Why?
| Canada | 3 | 2007 | 322 | 0.080 |
Why?
| Biomarkers | 4 | 2021 | 3408 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2013 | 2540 | 0.070 |
Why?
| Vitamins | 1 | 2009 | 151 | 0.070 |
Why?
| Parkinson Disease | 1 | 2012 | 345 | 0.070 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 364 | 0.070 |
Why?
| Triglycerides | 2 | 2003 | 467 | 0.070 |
Why?
| Myosin Heavy Chains | 1 | 2008 | 177 | 0.070 |
Why?
| Task Performance and Analysis | 1 | 2007 | 159 | 0.070 |
Why?
| Atrial Natriuretic Factor | 1 | 2006 | 55 | 0.070 |
Why?
| Antigens, Neoplasm | 1 | 2008 | 222 | 0.070 |
Why?
| Pharmacogenetics | 1 | 2007 | 149 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2021 | 1693 | 0.070 |
Why?
| Blood Glucose | 3 | 2018 | 1828 | 0.070 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2005 | 28 | 0.060 |
Why?
| Liver Transplantation | 1 | 2013 | 707 | 0.060 |
Why?
| Membrane Glycoproteins | 1 | 2008 | 430 | 0.060 |
Why?
| Lipoproteins, LDL | 1 | 2005 | 128 | 0.060 |
Why?
| Biological Availability | 2 | 2012 | 119 | 0.060 |
Why?
| ErbB Receptors | 1 | 2008 | 554 | 0.060 |
Why?
| Surveys and Questionnaires | 2 | 2013 | 4624 | 0.060 |
Why?
| Anxiety Disorders | 2 | 2021 | 303 | 0.060 |
Why?
| Metabolome | 2 | 2018 | 282 | 0.060 |
Why?
| Tobacco Products | 2 | 2019 | 98 | 0.060 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1473 | 0.060 |
Why?
| Cognition Disorders | 1 | 2007 | 476 | 0.050 |
Why?
| China | 2 | 2007 | 161 | 0.050 |
Why?
| Postoperative Complications | 1 | 2014 | 2128 | 0.050 |
Why?
| Child | 8 | 2021 | 18420 | 0.050 |
Why?
| Prognosis | 3 | 2021 | 3329 | 0.050 |
Why?
| Analysis of Variance | 1 | 2006 | 1226 | 0.050 |
Why?
| Time Factors | 3 | 2020 | 6116 | 0.050 |
Why?
| Depressive Disorder, Major | 2 | 2020 | 301 | 0.050 |
Why?
| Sample Size | 1 | 2022 | 112 | 0.050 |
Why?
| Pilot Projects | 2 | 2017 | 1373 | 0.050 |
Why?
| Comorbidity | 3 | 2013 | 1448 | 0.050 |
Why?
| Dietary Supplements | 2 | 2015 | 460 | 0.050 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2021 | 34 | 0.050 |
Why?
| Virion | 1 | 2021 | 73 | 0.050 |
Why?
| Ontario | 1 | 2020 | 74 | 0.040 |
Why?
| Sex Factors | 3 | 2013 | 1715 | 0.040 |
Why?
| Patient Selection | 2 | 2008 | 641 | 0.040 |
Why?
| Stroke | 1 | 2009 | 1022 | 0.040 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 230 | 0.040 |
Why?
| Serotonin | 2 | 1999 | 292 | 0.040 |
Why?
| Molecular Diagnostic Techniques | 1 | 2021 | 91 | 0.040 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 993 | 0.040 |
Why?
| Specimen Handling | 1 | 2021 | 155 | 0.040 |
Why?
| Cohort Studies | 4 | 2014 | 4895 | 0.040 |
Why?
| Computer Simulation | 3 | 2010 | 873 | 0.040 |
Why?
| Opioid Peptides | 1 | 1999 | 4 | 0.040 |
Why?
| Asia, Southeastern | 1 | 1998 | 10 | 0.040 |
Why?
| Escape Reaction | 1 | 1999 | 58 | 0.040 |
Why?
| Emergency Service, Hospital | 2 | 2020 | 1820 | 0.040 |
Why?
| Genetics, Behavioral | 1 | 2019 | 43 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2005 | 1314 | 0.040 |
Why?
| Helplessness, Learned | 1 | 1999 | 61 | 0.040 |
Why?
| Potassium, Dietary | 1 | 2018 | 10 | 0.040 |
Why?
| Bayes Theorem | 1 | 2020 | 329 | 0.040 |
Why?
| Oxidative Stress | 2 | 2016 | 1076 | 0.040 |
Why?
| United Kingdom | 1 | 2019 | 226 | 0.040 |
Why?
| Pyridinium Compounds | 1 | 2018 | 13 | 0.040 |
Why?
| Anxiety | 2 | 2021 | 840 | 0.040 |
Why?
| Infusions, Intravenous | 2 | 1997 | 371 | 0.040 |
Why?
| Methionine | 1 | 2018 | 144 | 0.040 |
Why?
| Transcription Factors | 1 | 2005 | 1528 | 0.040 |
Why?
| Death | 1 | 2018 | 107 | 0.040 |
Why?
| RNA, Viral | 1 | 2021 | 565 | 0.040 |
Why?
| Chromosomes, Human | 1 | 2017 | 39 | 0.040 |
Why?
| Transcriptome | 1 | 2022 | 725 | 0.040 |
Why?
| Absorption | 1 | 1997 | 52 | 0.030 |
Why?
| Models, Biological | 2 | 2010 | 1621 | 0.030 |
Why?
| Injections, Subcutaneous | 1 | 1997 | 134 | 0.030 |
Why?
| Mortality | 1 | 2018 | 287 | 0.030 |
Why?
| RNA, Bacterial | 1 | 2017 | 174 | 0.030 |
Why?
| Mental Health | 1 | 2021 | 562 | 0.030 |
Why?
| Fear | 1 | 1999 | 293 | 0.030 |
Why?
| DNA, Bacterial | 1 | 2017 | 311 | 0.030 |
Why?
| Stress, Physiological | 1 | 1999 | 378 | 0.030 |
Why?
| Methemoglobin | 1 | 2015 | 19 | 0.030 |
Why?
| Lung Neoplasms | 1 | 2008 | 2177 | 0.030 |
Why?
| Forearm | 1 | 2016 | 112 | 0.030 |
Why?
| Fatty Acids | 1 | 2018 | 381 | 0.030 |
Why?
| Acetylcholine | 1 | 2016 | 166 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2018 | 444 | 0.030 |
Why?
| Datasets as Topic | 1 | 2016 | 100 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2017 | 485 | 0.030 |
Why?
| Glomerular Filtration Rate | 1 | 2018 | 604 | 0.030 |
Why?
| Mice, Congenic | 1 | 2015 | 21 | 0.030 |
Why?
| Elasticity | 1 | 2015 | 189 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 740 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2015 | 207 | 0.030 |
Why?
| Sibling Relations | 1 | 2014 | 10 | 0.030 |
Why?
| Brain Chemistry | 2 | 2009 | 115 | 0.030 |
Why?
| Urban Health | 1 | 2014 | 73 | 0.030 |
Why?
| Mass Screening | 1 | 2021 | 1005 | 0.030 |
Why?
| Regression Analysis | 1 | 1997 | 945 | 0.030 |
Why?
| Rural Health | 1 | 2014 | 67 | 0.030 |
Why?
| Inheritance Patterns | 1 | 2014 | 45 | 0.030 |
Why?
| Heart Failure | 1 | 2006 | 1945 | 0.030 |
Why?
| Mobility Limitation | 1 | 2014 | 60 | 0.030 |
Why?
| Incidence | 1 | 2019 | 2313 | 0.030 |
Why?
| Pandemics | 1 | 2021 | 1320 | 0.030 |
Why?
| DEAD Box Protein 58 | 1 | 2013 | 8 | 0.030 |
Why?
| Unsafe Sex | 1 | 2013 | 58 | 0.030 |
Why?
| Age Distribution | 1 | 2014 | 342 | 0.030 |
Why?
| Mice | 3 | 2015 | 14871 | 0.030 |
Why?
| Research Design | 1 | 1998 | 928 | 0.030 |
Why?
| Genomics | 1 | 2017 | 635 | 0.030 |
Why?
| Vasodilation | 1 | 2015 | 419 | 0.030 |
Why?
| Condoms | 1 | 2013 | 113 | 0.030 |
Why?
| Hospitalization | 1 | 2021 | 1752 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2013 | 4411 | 0.030 |
Why?
| Microcirculation | 1 | 2012 | 135 | 0.020 |
Why?
| Apolipoproteins | 1 | 1992 | 36 | 0.020 |
Why?
| Interferons | 1 | 2013 | 151 | 0.020 |
Why?
| Drug Tolerance | 1 | 1992 | 79 | 0.020 |
Why?
| Logistic Models | 1 | 2016 | 1841 | 0.020 |
Why?
| Urban Population | 1 | 2014 | 397 | 0.020 |
Why?
| Muscle Strength | 1 | 2014 | 271 | 0.020 |
Why?
| Vascular Resistance | 1 | 2012 | 337 | 0.020 |
Why?
| Neurons | 1 | 1999 | 1280 | 0.020 |
Why?
| Animals | 5 | 2015 | 31708 | 0.020 |
Why?
| Cross-Over Studies | 1 | 2012 | 440 | 0.020 |
Why?
| Infusions, Parenteral | 1 | 1991 | 36 | 0.020 |
Why?
| Phobic Disorders | 1 | 2011 | 25 | 0.020 |
Why?
| Nitric Oxide | 1 | 2015 | 823 | 0.020 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 56 | 0.020 |
Why?
| Recovery of Function | 1 | 2014 | 574 | 0.020 |
Why?
| Rodentia | 1 | 2010 | 44 | 0.020 |
Why?
| Sodium Chloride | 1 | 1991 | 136 | 0.020 |
Why?
| Recurrence | 1 | 2013 | 935 | 0.020 |
Why?
| Inflammation | 1 | 2020 | 2480 | 0.020 |
Why?
| Fluid Therapy | 1 | 1991 | 123 | 0.020 |
Why?
| Dizziness | 1 | 2010 | 70 | 0.020 |
Why?
| Coronary Disease | 1 | 1992 | 348 | 0.020 |
Why?
| Nuclear Family | 1 | 2009 | 49 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 396 | 0.020 |
Why?
| Alcohol-Induced Disorders, Nervous System | 1 | 2009 | 6 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2010 | 175 | 0.020 |
Why?
| Vitamin B 6 | 1 | 2009 | 9 | 0.020 |
Why?
| Biopsy | 1 | 2013 | 1036 | 0.020 |
Why?
| Fertility | 1 | 2010 | 130 | 0.020 |
Why?
| Vitamin B Complex | 1 | 2009 | 38 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1842 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2009 | 493 | 0.020 |
Why?
| Tetraspanins | 1 | 2008 | 15 | 0.020 |
Why?
| Vitamin B 12 | 1 | 2009 | 115 | 0.020 |
Why?
| Receptors, Opioid, mu | 1 | 2008 | 52 | 0.020 |
Why?
| Folic Acid | 1 | 2009 | 161 | 0.020 |
Why?
| Medical History Taking | 1 | 2008 | 114 | 0.020 |
Why?
| Internet | 1 | 2012 | 596 | 0.020 |
Why?
| Bias | 1 | 2008 | 179 | 0.020 |
Why?
| Energy Intake | 1 | 2010 | 427 | 0.020 |
Why?
| Sri Lanka | 1 | 2007 | 7 | 0.020 |
Why?
| Preoperative Care | 1 | 2009 | 319 | 0.020 |
Why?
| Bangladesh | 1 | 2007 | 31 | 0.020 |
Why?
| Disability Evaluation | 1 | 2009 | 271 | 0.020 |
Why?
| Pakistan | 1 | 2007 | 73 | 0.020 |
Why?
| India | 1 | 2007 | 134 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 811 | 0.020 |
Why?
| Age of Onset | 1 | 2007 | 446 | 0.020 |
Why?
| Genes, Recessive | 1 | 2006 | 73 | 0.020 |
Why?
| Glucose Tolerance Test | 1 | 2007 | 343 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2010 | 1131 | 0.020 |
Why?
| Data Collection | 1 | 2008 | 620 | 0.020 |
Why?
| Dyslipidemias | 1 | 2007 | 154 | 0.020 |
Why?
| Linear Models | 1 | 2007 | 768 | 0.020 |
Why?
| 3' Untranslated Regions | 1 | 2005 | 129 | 0.020 |
Why?
| Liver | 1 | 2013 | 1637 | 0.020 |
Why?
| Heterozygote | 1 | 2005 | 251 | 0.020 |
Why?
| Asthma | 2 | 2010 | 2029 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2007 | 1075 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2014 | 4694 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2014 | 3535 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2010 | 1214 | 0.010 |
Why?
| Smoking Cessation | 1 | 2008 | 374 | 0.010 |
Why?
| Retrospective Studies | 1 | 2020 | 12555 | 0.010 |
Why?
| RNA | 1 | 2010 | 809 | 0.010 |
Why?
| Rats, Sprague-Dawley | 2 | 1999 | 2218 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 388 | 0.010 |
Why?
| Interleukin-10 | 1 | 2005 | 299 | 0.010 |
Why?
| Overweight | 1 | 2007 | 472 | 0.010 |
Why?
| Glucose | 1 | 2007 | 897 | 0.010 |
Why?
| Parents | 1 | 2010 | 1186 | 0.010 |
Why?
| DNA | 1 | 2008 | 1352 | 0.010 |
Why?
| Rats | 2 | 1999 | 4958 | 0.010 |
Why?
| Membrane Proteins | 1 | 2006 | 1019 | 0.010 |
Why?
| Reinforcement Schedule | 1 | 1999 | 29 | 0.010 |
Why?
| Microinjections | 1 | 1999 | 76 | 0.010 |
Why?
| Periaqueductal Gray | 1 | 1999 | 15 | 0.010 |
Why?
| Insulin Resistance | 1 | 2007 | 1072 | 0.010 |
Why?
| Electroshock | 1 | 1999 | 134 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 164 | 0.010 |
Why?
| Catheterization | 1 | 1999 | 159 | 0.010 |
Why?
| Naltrexone | 1 | 1999 | 83 | 0.010 |
Why?
| Morphine | 1 | 1999 | 121 | 0.010 |
Why?
| Narcotic Antagonists | 1 | 1999 | 136 | 0.010 |
Why?
| Insulin | 1 | 2007 | 2080 | 0.010 |
Why?
| Infant | 1 | 2008 | 7964 | 0.010 |
Why?
| Child, Preschool | 1 | 2008 | 9118 | 0.010 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2007 | 2096 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 1999 | 771 | 0.010 |
Why?
| Hyaluronoglucosaminidase | 1 | 1991 | 9 | 0.010 |
Why?
| Tritium | 1 | 1991 | 66 | 0.010 |
Why?
| Depression | 1 | 1999 | 1134 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1991 | 167 | 0.010 |
Why?
|
|
McQueen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|